Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects

Author(s): Jin-Wook Yoo, Elizabeth Chambers, Samir Mitragotri

Journal Name: Current Pharmaceutical Design

Volume 16 , Issue 21 , 2010

Become EABM
Become Reviewer


Numerous types of nanoparticles are being designed for systemic and targeted drug delivery. However, keeping nanoparticles in blood for sufficiently long times so as to allow them to reach their therapeutic target is a major challenge. Upon administration into blood, nanoparticles are quickly opsonized and cleared by the macrophages, thereby limiting their circulation times. Surface-modification of nanoparticles by PEG was developed as the first strategy to prolong nanoparticle circulation. While PEGylation has helped prolong particle circulation, it has several limitations including transient nature of the effect and compromised particle-target interactions. Accordingly, several other approaches have been developed to prolong nanoparticle circulation in blood. These include modification with CD47, modulation of mechanical properties, engineering particle morphology and hitchhiking on red blood cells. In this review, we discuss the factors that affect nanoparticle circulation time and discuss recent progress in development of strategies to prolong circulation time.

Keywords: Nanotechnology, targeting, long-circulation, macrophage, half-life, nanomedicine

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [2298 - 2307]
Pages: 10
DOI: 10.2174/138161210791920496
Price: $65

Article Metrics

PDF: 122